The Boston Institute of Biotechnology (BIB) is a premier contract development and manufacturing organization (CDMO) specializing in providing innovative solutions for the biopharmaceutical industry. With a focus on accelerating the development and production of biologics, BIB offers a comprehensive range of services, including process development, analytical testing, and GMP manufacturing.

BIB is dedicated to supporting clients at every stage of the bioprocessing lifecycle, from early-stage development to commercial production. Their state-of-the-art facilities and expert team of scientists and engineers ensure the delivery of high-quality, scalable, and cost-effective solutions tailored to meet the unique needs of each project.

With a commitment to excellence and innovation, the Boston Institute of Biotechnology partners with biopharmaceutical companies to overcome complex challenges in biologics development. Their expertise spans a wide array of therapeutic modalities, including monoclonal antibodies, recombinant proteins, and cell and gene therapies.

BIB’s mission is to empower clients to bring transformative therapies to market faster, improving patient outcomes and advancing global healthcare. By combining cutting-edge technology, scientific expertise, and a customer-centric approach, the Boston Institute of Biotechnology continues to be a trusted partner in the biopharmaceutical industry.